Diasome Pharmaceuticals, Inc.

CLEVELAND, OH · Founded 2008 · CIK 0001411617 · Biotech · Private

HDV™ platform for liver-targeted drug delivery

diasome.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$50M
7 Form D · Aug 2024
26 months since last filing
Contracts
—
No federal contracts on record
Patents
9
0 granted · 9 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$4,350,000
Private capital raisedForm D · SEC$12,084,000
Private capital raisedForm D · SEC$2,885,788
Private capital raisedForm D · SEC$1,500,000
Private capital raisedForm D · SEC$16,724,591
Private capital raisedForm D · SEC$8,999,998
Private capital raisedForm D · SEC$3,090,740
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2952PLUMB PHARMACEUTICALS, INC——
2953Stem Cell Development Fund, LLC—$2.8M
2954TISSUEFORM, INC.——
2955Diasome Pharmaceuticals, Inc.—$50M
2956ONCOCEUTICS, INC.——
2957INTEGRATED ANIMAL RESEARCH LLC——
2958TEZCAT Laboratories LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 15 related persons
  • Richard CarusoDirector
  • Brenda GavinDirector
  • Robert GehoDirector · Executive Officer · Promoter
  • W. GehoDirector · Executive Officer
  • W. Blair GehoDirector
  • Devang KantesariaDirector
  • Helga KautskyExecutive Officer
  • Frank McCaneyDirector
  • Thomas McDonaldDirector
  • Michele OllierDirector
  • Cosme OrdonezDirector
  • Marc PennDirector
  • Len RosenbergDirector · Executive Officer
  • Peter TollmanDirector
  • Guiseppe ZoccoDirector

Patents

USPTO · 0 granted of 9
  • Orally Bioavailable Lipid-based Constructsapplication
  • Lipid Construct For Delivery Of Insulin To A Mammalapplication
  • Orally Bioavailable Lipid-based Constructsapplication
  • Lipid Construct For Delivery Of Insulin To A Mammalapplication
  • Orally Bioavailable Lipid-based Constructsapplication
  • Orally Bioavailable Lipid-based Constructsapplication
  • Lipid Construct For Delivery Of Insulin To A Mammalapplication
  • Incretin Hormone Compositions And Methods Using Sameapplication
  • Incretin Hormone Compositions And Methods Using Sameapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.